Replies to post #206066 on Biotech Values

[DewDiligence]

TEVA may be doing a good job on Copaxone, but its overall prospects look rather bleak:

https://www.bloomberg.com/gadfly/articles/2016-11-15/teva-earnings-scale-needs-to-pay-off-soon